The Latest SPAC News and Rumors: May 24, 2022
by Marlena Haddad on 2022-05-24 at 11:45am

 


Below is a daily summary of links to the latest SPAC news and rumors gathered across the web. 

Latest SPAC News: Asia Innovations in talks to merge with E.Merge Technology and Alvotech announces positive results from clinical study for AVT04


Parent of Social Platform Uplive is Discussing Deal With E.Merge SPAC

Asia Innovations Group Ltd., the startup that operates social platform Uplive, is in talks to go public through a merger with E.Merge Technology Acquisition Corp. (NASDAQ:ETACU).

Any transaction is set to value the combined company at more than $2 billion. E.Merge is poised to begin formally canvassing PIPE investors for capital to support the transaction. Its company’s revenue more than doubled in 2021 to about $300 million.

READ

Alvotech Clinical Study Results Demonstrate Therapeutic Equivalence Between Biosimilar Candidate AVT04 and Reference Product Stelara

Alvotech Holdings S.A., a global biotech company focused solely on the development and manufacture of biosimilar medicines for patients worldwide, today announced positive results from a confirmatory clinical study for AVT04, Alvotech’s proposed biosimilar to Stelara®. Alvotech is the second company to announce positive results from a patient study utilizing a biosimilar candidate to Stelara®. Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is the exclusive strategic partner for the commercialization of AVT04 in the United States. STADA is the company’s exclusive strategic partner for AVT04 for the European market.

On December 7, 2021, Alvotech and Oaktree Acquisition Corp. II (NYSE: OACB), a special purpose acquisition company sponsored by an affiliate of Oaktree Capital Management, L.P., announced they had entered into a definitive business combination agreement.

READ

 

Recent Posts
by Kristi Marvin on 2024-10-29 at 8:22am

This week, we speak with Will Gray, co-Founder and CEO of New Era Helium and John Lipman, co-CEO and co-Chairman of Roth CH Acquisition V Co. (NASDAQ:ROCL). The two announced a business combination in January that would see New Era become a unique stock representing a resource that is not trading like most other commodities. Most...

by Nicholas Alan Clayton on 2024-10-29 at 8:22am

At the SPAC of Dawn With the US elections officially one week away, there has been big movement with the conservative quartet of de-SPACs, each of which seem to be riding some amount of retail enthusiasm into the polls. Black Rifle Coffee (NYSE:BRCC) has had the most muted week, but it nonetheless rose about +1%...

by Nicholas Alan Clayton on 2024-10-28 at 8:18am

At the SPAC of Dawn The final week of October comes in with a busy slate of votes including one extension today and nine more clustered on Thursday and Friday. Both TMT (NASDAQ:TMTC) and Insight (NASDAQ:INAQ) are set to hold completion votes for their combinations with eLong Power and Alpha Modus, respectively. Meanwhile, the SPAC...

by Kristi Marvin on 2024-10-26 at 10:00am

Terms Tracker for the Week Ending October 25, 2024 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. Finally, a little more SPAC action this week with no less than four IPOs priced.  That brings October’s tally to seven IPOs with one more...

by Nicholas Alan Clayton on 2024-10-25 at 8:15am

At the SPAC of Dawn The rebound of the growth companies that made up the SPAC class of 2021 has been one of the bigger stories of second half of 2024, but not all of the de-SPACs are feeling the love equally. Instead, in many new sectors that hit the public markets together as a...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved